Markets
AMD booth
(Xing Yun/Getty Images)

AMD slumps on no new big customer wins, with unexpected China sales driving AI revenue beat

Sometimes stocks just go down after reporting good results. Especially if they’d been going up a lot before that.

Is Advanced Micro Devices a software stock? Because even after reporting Q4 sales and earnings beats and a Q1 sales outlook ahead of Wall Street’s expectations, shares of the No. 2 name in GPUs are sliding.

A handful of potential reasons why:

  • Data center sales were merely in line with expectations after accounting for sales to China. This division posted sales of $5.38 billion versus a consensus estimate of $4.97 billion. But $390 million came from sales of MI308 chips to China. After Nvidia CFO Colette Kress said H20 demand from China “never materialized” after export restrictions were lifted, investors weren’t expecting AMD’s functional equivalent of that processor to be the swing factor in delivering better-than-anticipated results from this key segment.

  • No big customer wins. We’re living in a world where press releases touting new major customers and partnership as well as flashy reveals on conference calls are par for the course. AMD CEO Dr. Lisa Su and CFO Jean Hu offered none of the above, with Barclays analyst Tom O’Malley flagging that “management is signaling they won’t announce all new customers.” Well, yes, but you can bet if AMD had a major win to share, they’d share it! They’d almost be obligated to. And a big cause of the plethora of price target hikes that AMD received in the wake of its megadeal with OpenAI was the presumption that this pact would beget more major buyers to choose its AI processors.

  • The company isn’t doing a fantastic job of expense control. Better-than-expected adjusted gross margins “was more than offset by operating expense that was ~$200MM higher than guidance (a ~200 bps OpM headwind), marking several quarters of AMD overshooting expenses,” JPMorgan analyst Harlan Sur wrote. “So, though Mar-Qtr guidance was also better than expected, the extent to which AMD is able to generate operating leverage remains in question and likely represents an overhang on the stock until this can be satisfactorily demonstrated (most likely 2H26), especially in light of risk to gross margins with the upcoming ramp of MI450/Helios later this year.”

If all this sounds narratively unsatisfying when presented against the surface-level reality of results and guidance coming in ahead of expectations, well, that’s because it is.

“We were surprised at aftermarket weakness, as all the numbers were quite good and AMD said the right stuff about the new products,” wrote Morgan Stanley analyst Joseph Moore.

Sometimes stocks just fall after reporting better-than-expected quarterly figures and outlooks. Again, ask basically any software company that’s released results recently.

But unlike those tech companies that are in free fall, AMD had been performing very well year to date heading into this report. The stock matched its longest winning streak since 2005 en route to a 13% gain, besting the VanEck Semiconductor ETF by about 2.5 percentage point and trouncing Nvidia, which is down 3.3% in 2026.

These results reaffirm that this relative performance has come despite AMD being significantly smaller and still posting substantially slower top-line growth than its GPU overlord.

More Markets

See all Markets
markets

Broadcom soars on Google’s plans for up to $185 billion in capex this year

Google’s capex guidance is Broadcom’s earnings guidance.

The hyperscaler and search giant said its 2026 capex budget would be between $175 billion and $185 billion, 55% higher than Wall Street had anticipated.

Accordingly, shares of the custom chip specialist are soaring in after-hours trading.

Broadcom has enjoyed a halo effect from Google’s capex plans and the success of its Gemini 3 model (trained on TPUs the two companies codesigned) over the past year.

But the custom chip designer had tumbled after its most recent earnings report, with some analysts attributing the decline to the dearth of new customer announcements. But who needs new customers when your current ones are opening their wallets this much?!?

Accordingly, shares of the custom chip specialist are soaring in after-hours trading.

Broadcom has enjoyed a halo effect from Google’s capex plans and the success of its Gemini 3 model (trained on TPUs the two companies codesigned) over the past year.

But the custom chip designer had tumbled after its most recent earnings report, with some analysts attributing the decline to the dearth of new customer announcements. But who needs new customers when your current ones are opening their wallets this much?!?

(J. Edward Moreno/Sherwood News)

Novo and Lilly agree prices are falling — and disagree on what comes next

Novo Nordisk and Eli Lilly are cutting prices to reach more patients — with sharply different expectations about what that means for sales.

markets

Ozempic is no longer the most searched for GLP-1 in the US

Ozempic, the popular diabetes drug made by Novo Nordisk, used to be shorthand for an entire class of diabetes and weight-loss medications. Not anymore.

According to Google Trends data, as of January, more people in the US are searching for Eli Lilly’s weight-loss shot, Zepbound, than Ozempic. At the same time, interest in the word “Ozempic” now sits roughly on par with searches for “peptides,” a catchall term for a booming, loosely regulated category of experimental supplements.

The numbers hint at a cultural shift: Ozempic is no longer the only word people reach for when they think about weight-loss drugs. The market — and the vocabulary around it — is fragmenting.

This shift also reflected in sales numbers. For several quarters now, Lillys diabetes and weight-loss drugs have outsold Novos, and that gap is expected to widen this year.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.